Comparing Accolate vs Singulair
Accolate (zafirlukast) | Singulair (montelukast) |
|
---|
Accolate (zafirlukast) | Singulair (montelukast) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Asthma - Maintenance. Accolate may also be used for purposes not listed in this medication guide. |
Prescription only
Singulair is used in addition to other treatments for the maintenance treatment of asthma. It does not relieve acute attacks and may cause neuropsychiatric effects in a small number of people... View more |
Related suggestions Asthma, Maintenance
|
|||||||
More about Accolate (zafirlukast) | More about Singulair (montelukast) | ||||||||
Ratings & Reviews | |||||||||
Accolate has an average rating of 9.8 out of 10 from a total of 4 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Singulair has an average rating of 6.6 out of 10 from a total of 221 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 30% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Accolate side effects |
View all Singulair side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Singulair prices |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
N/A |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
10 hours |
5.5 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 301 drugs are known to interact with Accolate:
|
A total of 117 drugs are known to interact with Singulair:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
September 26, 1996 |
February 20, 1998 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Xolair
Xolair injection (omalizumab) is used to help improve allergic asthma, nasal polyps, and chronic ...
Symbicort
Symbicort (budesonide and formoterol) is used to prevent bronchospasm in people with asthma or ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Ventolin HFA
Ventolin HFA (albuterol) is used to treat or prevent breathing problems in patients who have asthma ...
Ventolin
Ventolin is used for asthma, acute, asthma, maintenance, bronchiectasis, bronchospasm prophylaxis ...
Breo Ellipta
Breo Ellipta (fluticasone and vilanterol) is used to prevent airflow obstruction or bronchospasm in ...
Spiriva
Spiriva (tiotropium) is used to prevent bronchospasm in people with bronchitis, emphysema, or COPD ...
Xopenex
Xopenex is a short-acting bronchodilator used to treat or prevent bronchospasm in asthma and other ...
Dulera
Dulera Inhalers (formoterol and mometasone) are used to treat asthma. Includes Dulera side effects ...
Spiriva Respimat
Spiriva Respimat is used for asthma, maintenance, COPD, Maintenance
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.